Classification
Product TypeIngredient
Product FormFreeze-dried probiotic culture (powder) / finished dietary supplement forms (capsules, powders)
Industry PositionDietary Supplement Ingredient (Probiotics)
Market
Lactobacillus (probiotic lactic-acid bacteria, typically identified on labels at genus–species–strain level) is widely sold in the United States as a dietary supplement ingredient and in finished probiotic supplements. In the U.S., probiotic supplements are regulated by FDA as dietary supplements (a category of food) under DSHEA, with manufacturing, packaging, labeling, and holding operations subject to dietary supplement cGMP requirements (21 CFR Part 111). Market access depends heavily on compliant labeling and claim practices (e.g., structure/function claim disclaimer and FDA notification) and on quality controls that support identity and viable counts (CFUs) through shelf life with appropriate storage instructions. Imports of probiotic ingredients and finished products must meet FDA import requirements (including Prior Notice) and can face detention/refusal if they appear violative or are subject to an Import Alert.
Market RoleDomestic consumption market supplied by both domestic and imported probiotic ingredients and finished dietary supplements
Domestic RoleCommon dietary supplement ingredient (live microbial/probiotic) used in finished probiotic supplements; also used in some foods
Risks
Regulatory Compliance HighFDA Import Alerts can result in Detention Without Physical Examination (DWPE), disrupting or blocking imports of probiotic dietary supplement ingredients or finished products that appear to violate U.S. requirements (e.g., adulteration, misbranding, or other compliance concerns).Pre-screen the FDA Import Alert database; conduct pre-shipment label/claim and documentation checks; maintain cGMP evidence and quality documentation to address ‘appearance of violation’ concerns.
Regulatory Compliance MediumIf a probiotic strain is deemed a New Dietary Ingredient (NDI) and the required NDI notification has not been submitted to FDA, the dietary supplement can be deemed adulterated under U.S. law, creating a serious market access and enforcement risk.Perform an NDI determination for each strain and form; if required, submit an NDI notification with a safety basis at least 75 days prior to marketing and maintain supporting documentation.
Labeling And Claims MediumStructure/function and other health-related claims face dual scrutiny: FDA labeling requirements (including disclaimer and post-market claim notification timelines) and FTC advertising substantiation expectations; noncompliant claims can trigger enforcement, recalls, or import disruptions.Implement a claim review workflow aligned to FDA DSHEA labeling requirements and FTC substantiation principles; retain evidence files supporting express and implied claims.
Quality MediumProbiotic potency is commonly expressed as CFUs, but CFU counts can decline over time and depend on storage conditions; products that do not maintain viable counts consistent with labeling expectations may face quality complaints, recalls, or retailer delisting risk in the U.S.Set stability and release specifications that align with label claims (including whether CFUs are stated at manufacture or through expiration); control storage conditions per label and validate shelf-life performance.
Logistics MediumImport delays or handling outside labeled storage conditions can reduce viability (CFUs), increasing risk of out-of-spec product upon arrival or at retail in the U.S.Use validated packaging and transit controls consistent with label storage instructions; design logistics plans that minimize dwell time and include temperature/handling monitoring where appropriate.
Standards- NSF/ANSI 173 dietary supplement certification (identity/label-claim and contaminant-focused third-party certification)
- NSF Certified for Sport® (channel-specific third-party testing/certification for banned substances, in addition to baseline certification requirements)
- USP Dietary Supplement Verification Program (third-party verification mark used in U.S. market quality signaling)
FAQ
Is Lactobacillus (a probiotic) considered a dietary ingredient in the United States?Yes. FDA’s dietary supplement Q&A notes that “dietary substances” that are part of the food supply can include live microbials (commonly referred to as probiotics), which can be used as dietary ingredients in dietary supplements under DSHEA.
When would a U.S. New Dietary Ingredient (NDI) notification be relevant for a probiotic strain?FDA explains that an NDI is a dietary ingredient not marketed in the United States in a dietary supplement before October 15, 1994, and that certain products containing an NDI require a premarket notification to FDA at least 75 days before introduction into interstate commerce. If an NDI notification is required and the product is marketed without it, FDA describes the product as adulterated under U.S. law.
What label information is commonly expected for probiotic supplements in the U.S.?NIH’s Office of Dietary Supplements explains that probiotic microorganisms are named by genus, species, and strain and that labels can include strain information, expiration/use-by date, storage instructions (room temperature vs refrigerated depending on product), and CFU information. FDA also describes required dietary supplement labeling elements such as the Supplement Facts panel.
What are key U.S. import compliance steps for probiotic dietary supplements or dietary ingredients?FDA states that Prior Notice is required for imported foods subject to the regulation, including dietary supplements and dietary ingredients. FDA also explains that Import Alerts can result in detention without physical examination (DWPE) for products with a history of violations, which can block entry unless the appearance of the violation is overcome.